Advances in the role of epigenetics in homocysteine-related diseases

Epigenomics. 2023 Aug;15(15):769-795. doi: 10.2217/epi-2023-0207. Epub 2023 Sep 18.

Abstract

Homocysteine has a wide range of biological effects. However, the specific molecular mechanism of its pathogenicity is still unclear. The diseases induced by hyperhomocysteinemia (HHcy) are called homocysteine-related diseases. Clinical treatment of HHcy is mainly through folic acid and B-complex vitamins, which are not effective in reducing the associated end point events. Epigenetics is the alteration of heritable genes caused by DNA methylation, histone modification, noncoding RNAs and chromatin remodeling without altering the DNA sequence. In recent years the role of epigenetics in homocysteine-associated diseases has been gradually discovered. This article summarizes the latest evidence on the role of epigenetics in HHcy, providing new directions for its prevention and treatment.

Keywords: DNA methylation; epigenetics; histone modifications; homocysteine; noncoding RNAs.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chromatin Assembly and Disassembly
  • DNA Methylation*
  • Epigenesis, Genetic*
  • Epigenomics
  • Homocysteine
  • Humans

Substances

  • Homocysteine